Third, when compared to that in normal tissues, PROM2 was significantly overexpressed in breast, lung, bone marrow, and ovarian cancers, whereas it was underexpressed in colon, esophageal, gastric, kidney, prostate, and skin cancers (Subbroto et al., 2020). Here, PROM2 is linked to skin cancer.